Pavic, Michel

1 paper on CoChatORCID 0000-0002-7057-7492

Most cited papers

Verified
Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial
Richardson, P. G., Oriol, A., Beksac, M., Liberati, A. M., Galli, M., Schjesvold, F., Lindsay, J., Weisel, K., White, D., Facon, T., et al. (2019) · The Lancet Oncology
Multiple Myeloma Research and TreatmentsBone health and treatments
Cited by 386

Go further with a free account

Verify every reference, keep papers in a library, and ask questions across them.

Sign up - it is free